ARCHIVES

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

NCI To Fund Two Construction Grants With 42 Million From Special NIH Fund

March 2, 1990

Newcomers Undercut Price of BRCA Test; Myriad Lawsuits Claim Patent Infringement

July 25, 2013

NS Offers Research Grants, Scholarships

September 22, 1989

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

February 25, 2011

In Brief: Lasagna Committee Report Finalized; Robinson Replaces Schmidt On MSK Boards

July 13, 1990

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986